BBB National Programs Decision Summaries

BBB National Programs provides summaries of all case decisions from the National Advertising Division (NAD), National Advertising Review Board (NARB), Children’s Advertising Review Unit (CARU), Direct Selling Self-Regulatory Council (DSSRC), and Digital Advertising Accountability Program (DAAP). Subscribe to receive a weekly wrap-up of published case decisions in your inbox.

 

For the full text of NAD, NARB, and CARU decisions, subscribe to the Online Archive. Other case decisions are available publicly: DSSRC and DAAP. For members of the press, the full text of any BBB National Programs decision is available by emailing the request to press@bbbnp.org.
  • 12/16/2019 - NARB Recommends Native Cosmetics Discontinue Moisture Absorption and Underarm Wetness Protection Claims for Native Deodorant

    A panel of the National Advertising Review Board (NARB) has found that Zenlen Inc. d/b/a Native Cosmetics (Native) failed to provide a reasonable basis for two related claims made by Native – that Native deodorants “absorb” underarm wetness and provide effective protection against wetness, and recommended that such claims be discontinued. The advertising at issue had been challenged by Tom’s of Maine, maker of competing deodorant products, before the National Advertising Division (NAD), an investigative unit of the advertising industry’s system of self-regulation.  Following NAD’s decision, Native appealed to the NARB, the appellate unit of the advertising industry’s system of self-regulation.
  • 10/23/2019 - NARB Recommends Goya Discontinue Claim that Excelsior Pasta is “La pasta favorita de Puerto Rico,” Following Challenge by Maker of Ronzoni Pasta

    A panel of the National Advertising Review Board (NARB) has found that Goya Foods, Inc.’s claim that its Excelsior brand pasta is “La pasta favorita de Puerto Rico” (translated as “The Favorite Pasta of Puerto Rico” or “Puerto Rico’s Favorite Pasta”) (the “Favorite Claim” or “Claim) is an unsupported objective preference claim and should be withdrawn.
  • 8/28/2019 - NARB Refers Advertising Claims Made by J-B Weld Company to Federal Trade Commission After Company Declines to Comply with NARB Recommendations

    The National Advertising Review Board (NARB) has referred advertising claims made by J-B Weld Company, LLC to the Federal Trade Commission (FTC) for review after the company declined to comply with NARB’s recommendations regarding discontinuation of “Made in USA” advertising claims made on certain product packaging and in online advertisements for its silicon and epoxy adhesive products.
  • 8/20/2019 - NARB Recommends AT&T Modify, Discontinue 99% Reliability Claims for its Internet Services, Approves Other Monadic Claims, Following Charter Challenge

    A panel of the National Advertising Review Board (NARB) has found that AT&T Services, Inc.’s claims that its internet services delivers over 99% reliability, made in certain advertisements, are unsupported and recommended that the claims be discontinued or modified. 
  • 8/12/2019 - NARB Recommends AT&T Discontinue Comparative Reliability Claim in its “Historic Launch” Commercial, Following Comcast Challenge

    A panel of the National Advertising Review Board (NARB) has found that an AT&T Services Inc. television commercial (the “Historic Launch”) conveys an unsupported claim that with over 99% reliability, its services are superior compared to at least one viable competitive service, and recommended that the message be discontinued.
  • 8/06/2019 - NARB Recommends Modification of Advertising Claims for Sonicare DiamondClean Electric Toothbrush; Upholds Validity of Philips Oral Healthcare Clinical Study

    A panel of the National Advertising Review Board (NARB) has recommended that Philips Oral Healthcare, Inc., modify certain advertising claims for the company’s Sonicare DiamondClean electric toothbrush.  The advertising at issue had been challenged by The Procter & Gamble Company, manufacturer of the competing Oral-B brand electric toothbrushes, before the National Advertising Division (NAD). The NAD is an investigative unit of the advertising industry’s system of self-regulation and is a division of the BBBNP’s self-regulatory and dispute resolution programs.  Following NAD’s decision, Philips appealed all of the NAD recommendations adverse to it to the NARB, the appellate unit of the advertising industry’s system of self-regulation. P&G exercised its right under the applicable rules of procedure to file a cross-appeal.
  • 6/12/2019 - NARB Recommends Chattem Discontinue Certain Claims for ACT Dry Mouth Mouthwash and ACT Dry Mouth Lozenges; Approves Others

    A panel of the Advertising Review Board (NARB) has recommended that Chattem, Inc. discontinue certain advertising claims for ACT Dry Mouth Mouthwash and ACT Dry Mouth Lozenges, while also approving others. The advertising at issue had been challenged by GlaxoSmithKline Consumer Healthcare, L.P., the manufacturer of the competing Biotene brand oral care products, before the National Advertising Division (NAD).  The NAD is an investigative unit of the advertising industry’s system of self-regulation administered by the Council of Better Business Bureaus.  Following the NAD’s decision, Chattem appealed certain recommendations made by NAD to the NARB, the appellate unit of the advertising industry’s system of self-regulation. GSK exercised its right under the applicable rules of procedure to file a cross-appeal.
  • 6/11/2019 - NARB Recommends AT&T Modify or Discontinue One Advertisement, Approves Another, in its “More For Your Thing – That’s Our Thing” Campaign, Following T-Mobile Challenge

    A panel of the National Advertising Review Board (NARB) has found that an AT&T Services Inc. internet advertisement claiming “More for Your Stream Like a Boss Thing” conveys an unsupported superiority claim comparing AT&T to its competitors, and recommended that it be modified or discontinued.  In the same proceeding, NARB found in favor of AT&T with regard to its “Do Your Thing” commercial. 
  • 5/09/2019 - NARB Recommends Eli Nutrition Discontinue Certain Antacid Claims Made for TummyZen Dietary Supplement, Approves Other Claims

    A panel of the National Advertising Review Board (NARB) has recommended that Eli Nutrition, Inc. discontinue certain advertising claims (while also approving others) made on product packaging and in online advertising for Eli Nutrition’s TummyZen  dietary supplement.  TummyZen is an antacid containing calcium carbonate and zinc.  The advertising at issue had been challenged by GlaxoSmithKline Consumer Healthcare, L.P., which sells Tums,  before the National Advertising Division (NAD).  The NAD is an investigative unit of the advertising industry’s system of self-regulation administered by the Council of Better Business Bureaus.  Following the NAD’s decision, Eli Nutrition appealed to the NARB, the appellate unit of the advertising industry’s system of self-regulation.
  • 4/23/2019 - NARB Recommends Comcast Modify Comparative Claims For Xfinity Service Following Challenge By DirecTV

    A panel of the National Advertising Review Board (NARB) has recommended that Comcast Communications, LLC modify its advertising to avoid making unsupported implied superiority claims. The advertising claims that were the subject of the panel’s review related to the comparison of Comcast’s Xfinity Television Service, a cable service with features of DirecTV, a competing satellite service operated by DirecTV, LLC.